Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H37FO5 |
Molecular Weight | 460.5781 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C
InChI
InChIKey=XZBJVIQXJHGUBE-HZMVJJPJSA-N
InChI=1S/C27H37FO5/c1-14-9-17-16-11-19(28)18-10-15(29)7-8-26(18,5)23(16)20(30)12-27(17,6)22(14)21(31)13-33-24(32)25(2,3)4/h7-8,10,14,16-17,19-20,22-23,30H,9,11-13H2,1-6H3/t14-,16+,17+,19+,20+,22-,23-,26+,27+/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12650700 | https://www.ncbi.nlm.nih.gov/pubmed/3743619Curator's Comment: description was created based on several sources, including
http://www.druginfosys.com/Drug.aspx?DrugCode=1121&DrugName=Fluocortolone&type=1
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12650700 | https://www.ncbi.nlm.nih.gov/pubmed/3743619
Curator's Comment: description was created based on several sources, including
http://www.druginfosys.com/Drug.aspx?DrugCode=1121&DrugName=Fluocortolone&type=1
Fluocortolone is a topical corticosteroid (class of steroid hormones formed in the adrenal gland). Is primary indicated in condition like, Ana fissure, Dermatosis haemorrhoids, proctitis. The signs and symptoms that are produced after the acute overdosage include convulsions, respiratory arrest, allergic skin reactions. Glucocorticoids, such as fluocortolone, act through nuclear hormone receptors Schaaf and Cidlowski (2002). The two members of this family are glucocorticoid receptor (GR) type I and GR type I I. Activation of these sites alters gene expression of endogenous agents that influence immune and inflammatory responses.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2034 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12650700 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. | 2003 Aug |
|
[Bilateral uveitis intermedia. A 15-year clinical course]. | 2003 Dec |
|
An integrative approach to eczema (atopic dermatitis). | 2003 Jan-Feb |
|
Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids. | 2003 Nov |
|
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. | 2010 Apr |
|
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy. | 2010 Jan |
|
Prevention and treatment of intertrigo in large skin folds of adults: a systematic review. | 2010 Jul 13 |
|
Update on the management of chronic eczema: new approaches and emerging treatment options. | 2010 Jul 28 |
|
Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching. | 2010 Nov 11 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
29205-06-9
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | |||
|
SUB02219MIG
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | |||
|
249-504-4
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | |||
|
DTXSID30951798
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | |||
|
9J8AL6K50Q
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | |||
|
119871
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | |||
|
4465
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000091889
Created by
admin on Sat Dec 16 05:10:55 GMT 2023 , Edited by admin on Sat Dec 16 05:10:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD